Skip to content

Sunday, October 25, 2026

Top Stories Global Economy Markets Topics & Series Contributors Opinion

All desks ⌄

Economy & Finance

Economy Investing Central Banks Digital Currency Fintech Research & Analysis Technicals

Power & Business

Politics Business Law Insights & Views Governance Market Roundups

Science & Society

Technology Science Nature Health Life

In focus · trending topic

Phase 1 Trial

1 stories · following the connections

A nurse checks an intravenous line beside a patient in an oncology clinic in Beijing, China. (AI-generated image / EconoTimes)

BeOne's BGB-B2033 Records a 36% Response Rate in Phase 1 Liver Cancer Study

By Naomi CalderOct 24, 2026, 5:51 PM UTC

←1→Page 1 of 1

Connected markets

Follow the indicators behind the story.

Illustrative data · 06 Oct 2026, 08:00 UTC

Keep exploring

California Skin cancer Paid Family Leave Parental Leave Regeneron Libtayo Cemiplimab C-POST trial

Coverage

Global Economy Markets Technology Politics All news

Intelligence

Topics & Series Contributors Research

Company

About us Become a contributor Contact info@econotimes.com Editorial standards

© 2026 PUBLISH Holdings LLC.Privacy Terms of use Our standards

Home Markets Topics Search